CRChristiane Rollenhagen

Christiane Rollenhagen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christiane Rollenhagen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in Women

    by Sharon M. Anderson, Andrea R. Thurman, Neelima Chandra, Suzanne S. Jackson, Susana Asin, Christiane Rollenhagen, Mimi Ghosh, Jason Daniels, Nikolas C. Vann, Meredith R. Clark, et al.

    While vitamin D insufficiency is known to impact a multitude of health outcomes, including HIV-1, little is known about the role of vitamin D-mediated immune regulation in the female reproductive tract (FRT). We performed a pilot clinical study of 20 women with circulating 25(OH)D levels <62.5 nmol/L. Participants were randomized into either weekly or daily high-dose oral vitamin D supplementation groups. In addition to serum vitamin D levels, genital mucosal endpoints, including soluble mediators, immune cell populations, gene expression, and ex vivo HIV-1 infection, were assessed. While systemic vitamin D levels showed a significant increase following supplementation, these changes translated into modest effects on the cervicovaginal factors studied. Paradoxically, post-supplementation vitamin D levels were decreased in cervicovaginal fluids. Given the strong correlation between vitamin D status and HIV-1 infection and the widespread nature of vitamin D deficiency, further understanding of the role of vitamin D immunoregulation in the female reproductive tract is important.


  • Open Access

    The Role of Secretory Pathways in Candida albicans Pathogenesis

    by Christiane Rollenhagen, Sahil Mamtani, Dakota Ma, Reva Dixit, Susan Eszterhas, Samuel A. Lee

    Candida albicans is a fungus that is a commensal organism and a member of the normal human microbiota. It has the ability to transition into an opportunistic invasive pathogen. Attributes that support pathogenesis include secretion of virulence-associated proteins, hyphal formation, and biofilm formation. These processes are supported by secretion, as defined in the broad context of membrane trafficking. In this review, we examine the role of secretory pathways in Candida virulence, with a focus on the model opportunistic fungal pathogen, Candida albicans.


  • Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women

    by Andrea Ries Thurman, Neelima Chandra, Nazita Yousefieh, Irina Zalenskaya, Thomas Dudley Kimble, Susana Asin, Christiane Rollenhagen, Sharon M. Anderson, Betsy Herold, Pedro M.M. Mesquita, et al.

    Objective: The purpose of this study was to evaluate differences in vaginal immune cell populations, vaginal tissue gene expression, anti-microbial activity of the cervicovaginal (CV) fluid lavage (CVL), vaginal flora and p24 antigen production from CV tissues after ex vivo HIV infection between the follicular (FOL) and luteal (LUT) phases of the menstrual cycle. Methods: CV tissue biopsies, CV secretions and blood samples were obtained as part of two longitudinal clinical trials of healthy women (CONRAD D11-119 and A12-124 studies). Participants (n = 39) were HIV seronegative women not using exogenous hormone supplementation, with normal menstrual cycles, who were screened to exclude sexually transmitted and reproductive tract infections. Results: Serum levels of estradiol and progesterone were significantly higher in the LUT versus the FOL phase of the menstrual cycle. Controlling for race, reported contraceptive use/sexual practices, and clinical trial, we found no differences in vaginal tissue immune cell populations and activation status, transcriptomes, inhibition of HIV, herpes simplex virus type 2 (HSV2) and Escherichia coli (E. coli) by the CVL, vaginal pH or Nugent score or production of p24 antigen after ex vivo infection by HIV-1BaL between CV samples obtained in the FOL versus the LUT phase of the menstrual cycle. There were no significant correlations between serum estradiol and progesterone levels and CV endpoints. Conclusion: The hypothesis that the LUT phase of the menstrual cycle represents a more vulnerable stage for mucosal infection with HIV was not supported by data from samples obtained from the lower genital tract (ectocervix and vagina) from these two clinical trials. Key Words: Follicular, Luteal, Menstrual Cycle, HIV acquisition, mucosa